Home
About
Solutions
Early detection of cancers
Phenotypic drug discovery
Phenotypic drug discovery strategy
Drug Safety
Drug-induced liver injury (DILI) detection
Idiosyncratic drug-induced liver injury (iDILI) detection
Drug efficacy
HCC model for small molecules targeted therapy
HCC model for adoptive cell therapy
Products for r&d
OneSmartDiff: a one step immune cell diffentation medium
News
Publications / Brochures
Menu
Home
About
Solutions
Early detection of cancers
Phenotypic drug discovery
Phenotypic drug discovery strategy
Drug Safety
Drug-induced liver injury (DILI) detection
Idiosyncratic drug-induced liver injury (iDILI) detection
Drug efficacy
HCC model for small molecules targeted therapy
HCC model for adoptive cell therapy
Products for r&d
OneSmartDiff: a one step immune cell diffentation medium
News
Publications / Brochures
publications / brochures
Toutes
Brochures
News
Publications
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
Publication
Publication
Brochure
Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone
Publication
Publication
Brochure
Detection of idiosyncratic drug-induced liver injury (iDILI) with the GenuineSelect-TOX system
Publication
Publication
Brochure
Home
About
Solutions
Early detection of cancers
Phenotypic drug discovery
Phenotypic drug discovery strategy
Drug Safety
Drug-induced liver injury (DILI) detection
Idiosyncratic drug-induced liver injury (iDILI) detection
Drug efficacy
HCC model for small molecules targeted therapy
HCC model for adoptive cell therapy
Products for r&d
OneSmartDiff: a one step immune cell diffentation medium
News
Publications / Brochures
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.
OK
Non
Politique de confidentialité